Biodesix Inc at Canaccord Genuity Growth Conference Transcript
I'm Kyle Mikson, I cover a lot of science tools and diagnostics for Canaccord. Pleased to have Biodesix here with us today. The company leverages multiomics and artificial intelligence to provide diagnostic solutions with a focus on lung cancer. With us from the company, we have CEO Scott Hutton. Scott, thanks for joining us today.
Yeah, thank you, Kyle.
Questions & Answers
Awesome, so maybe let's start with the quarter. You just provided, or just announced the second quarter results on, I guess, Monday. It's a very good quarter with volume and other metrics. Maybe just do a brief overview of how the quarter kind of shaped up and what the future near-term outlook kind of looks like.
Yeah, no, thank you. It was a great quarter for us. We really are focused on commercial expansion with five on-market tests, all
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
